Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Registration Number
- NCT00434395
- Lead Sponsor
- Bausch Health Americas, Inc.
- Brief Summary
The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Generally healthy subjects men or women aged 18-50
Exclusion Criteria
- Any significant clinically important disease
- Family history of long QT syndrome and/or sudden cardiac death
- Allergy to moxifloxacin or the quinolone class of antibiotics
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Cardiac repolarization will be assessed by the QTc interval in healthy subjects.
- Secondary Outcome Measures
Name Time Method